QPTFF (Quest PharmaTech) Common Stock: $22.32 Mil (As of Jan. 2026)


What is Quest PharmaTech Common Stock?

Quest PharmaTech QPTFF Common Stock is $22.32 Mil as of Jan. 2026.

Quest PharmaTech's quarterly common stock declined from Jul. 2025 ($22.45 Mil) to Oct. 2025 ($21.98 Mil) but then increased from Oct. 2025 ($21.98 Mil) to Jan. 2026 ($22.32 Mil).

Quest PharmaTech's annual common stock declined from Jan. 2024 ($22.90 Mil) to Jan. 2025 ($21.36 Mil) but then increased from Jan. 2025 ($21.36 Mil) to Jan. 2026 ($22.32 Mil).

Quest PharmaTech Common Stock Historical Data

* Premium members only.

The historical data trend for Quest PharmaTech's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Quest PharmaTech Common Stock Chart

Quest PharmaTech Annual Data
Trend Jan17 Jan18 Jan19 Jan20 Jan21 Jan22 Jan23 Jan24 Jan25 Jan26
Common Stock
Get a 7-Day Free Trial Premium Member Only Premium Member Only 24.26 22.90 22.90 21.36 22.32

Quest PharmaTech Quarterly Data
Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25 Apr25 Jul25 Oct25 Jan26
Common Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 21.36 21.99 22.45 21.98 22.32

Quest PharmaTech Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

Frequently Asked Questions Learn more about Common Stock →
What does a Common Stock of $22.32 Mil mean?
Quest PharmaTech (QPTFF) has a Common Stock of $22.32 Mil as of Jan. 2026. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on Quest PharmaTech and its competitors.
Is Quest PharmaTech's Common Stock too high?
Quest PharmaTech's current Common Stock is $22.32 Mil.
How does Quest PharmaTech's Common Stock compare to VRTX and REGN?
Quest PharmaTech's Common Stock of $22.32 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Common Stock for a Biotechnology company?
A good Common Stock depends on the Biotechnology industry context. However, Common Stock should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Common Stock mean?
A high Common Stock can signal that a stock is expensive relative to its fundamentals. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on Quest PharmaTech and its competitors. Quest PharmaTech's current Common Stock is $22.32 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Quest PharmaTech stock overvalued right now?
Quest PharmaTech (QPTFF) has a current Common Stock of $22.32 Mil. The current Common Stock is $22.32 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Common Stock calculated?
Common Stock is calculated from a company's financial statements. For Quest PharmaTech (QPTFF), the current Common Stock is $22.32 Mil as of Jan. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Quest PharmaTech Business Description

Other Exchanges QPT:Canada
Address 4342- 97 Street NW, Edmonton, AB, CAN, T6E 5R9
Quest PharmaTech Inc is developing targeted cancer therapy with its product (MAb AR9.6), under development for a novel target (truncated O-glycans on MUC16) discovered at the University of Nebraska Medical Center.